跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT04912024
NCT04912024已完成不适用

Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study (COMPARE)

Outset Medical2 个研究点 分布在 1 个国家目标入组 458 人开始时间: 2021年5月15日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
458
试验地点
2
主要终点
BUN Lab Value
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Retrospective, multicenter, comparative, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Renal Disease or Acute Kidney Injury.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —（Adult, Older Adult）
性别
All
接受健康志愿者
否

入选标准

  • •Participant is 18 years of age.
  • •Participant weighs ≥ 34kg.
  • •Participant was hospitalized and had dialysis dependent End-Stage Renal Disease or Acute Kidney Injury and was prescribed acute intermittent renal replacement therapy.

排除标准

  • •Treatments isolated to ultrafiltration only.
  • •Any documented condition the Physician feels would prevent the participant from successful inclusion in the study.

结局指标

主要结局

BUN Lab Value

时间窗: Change from baseline BUN measurement at 24 hours.

Change in Blood Urea Nitrogen

次要结局

  • Potassium Lab Value(Change from baseline potassium measurement at 24 hours)
  • Bicarbonate Lab Value(Change from baseline bicarbonate measurement at 24 hours.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
不适用
The EvAluation of TaBlo In-CLinic and In-HOmeEnd Stage Renal Disease
NCT02460263Outset Medical30
已完成
不适用
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)End Stage Renal DiseaseEnd Stage Renal Disease on DialysisDialysis HypotensionDialysis Induced Hypertension
NCT05540457The Rogosin Institute10
已完成
不适用
HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving HemodialysisEnd Stage Renal Disease (ESRD)
NCT01343251Merit Medical Systems, Inc.33
Unknown
不适用
Iron Therapy in Patients With End-Stage Renal DiseaseEnd-stage Renal DiseaseCardiovascular Risk FactorInflammationAnemia
NCT04491916Kaohsiung Medical University Chung-Ho Memorial Hospital200
已完成
3 期
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.Hepatitis B
NCT00291941Henogen300
Comparative Outcome Measures of Patients Receiving... | 临床试验